# Botox or Botox With Esophageal Dilation in Patients With Achalasia

> **NCT03654066** · PHASE4 · ENROLLING_BY_INVITATION · sponsor: **Vanderbilt University Medical Center** · enrollment: 50 (estimated)

## Conditions studied

- Achalasia

## Interventions

- **DRUG:** Botulinum toxin type A
- **DEVICE:** Endoscope balloon dilator
- **OTHER:** Patient reported outcomes
- **DIAGNOSTIC_TEST:** Barium esophagram

## Key facts

- **NCT ID:** NCT03654066
- **Lead sponsor:** Vanderbilt University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2019-05-13
- **Primary completion:** 2026-06
- **Final completion:** 2026-06
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03654066

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03654066, "Botox or Botox With Esophageal Dilation in Patients With Achalasia". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03654066. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*